Insulet Corp (STU:GOV)
€ 228.1 5 (2.24%) Market Cap: 17.41 Bil Enterprise Value: 17.87 Bil PE Ratio: 45.89 PB Ratio: 16.81 GF Score: 93/100

Insulet Corp at Raymond James Institutional Investors Conference Transcript

Mar 05, 2019 / 07:50PM GMT
Release Date Price: €82.07 (+2.33%)
Jayson Tyler Bedford
Raymond James & Associates, Inc., Research Division - Senior Medical Supplies and Devices Analyst

All right. Good afternoon. I think we're going to get started. Thanks, and welcome again to the second day here at the 40th Annual Raymond James Institutional Investors Conference. I'm Jayson Bedford, the medical device analyst. It's really our pleasure to have with us the senior management team of Insulet. Shacey Petrovic, the company's CEO, will be giving the presentation. So I'll hand it over to Shacey.

Shacey Petrovic
Insulet Corporation - President, CEO & Director

Thank you, Jayson.

(technical difficulty)

With insulin-dependent diabetes. And we do that through our innovative, disposable patch pump, the Omnipod. So you could see here Trent. In fact all of our presentation images and our marketing images are actual customers, and Trent is one of our Podders, he is wearing the Pod on his throwing arm here. And I really love this picture because it just so clearly illustrates the value of our technology. You can

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot